These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 27689909)

  • 41. Spatial distribution of Burkitt's lymphoma in Kenya and association with malaria risk.
    Rainey JJ; Mwanda WO; Wairiumu P; Moormann AM; Wilson ML; Rochford R
    Trop Med Int Health; 2007 Aug; 12(8):936-43. PubMed ID: 17697088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil.
    Klumb CE; Hassan R; De Oliveira DE; De Resende LM; Carriço MK; De Almeida Dobbin J; Pombo-De-Oliveira MS; Bacchi CE; Maia RC
    Int J Cancer; 2004 Jan; 108(1):66-70. PubMed ID: 14618617
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associations between Burkitt lymphoma among children in Malawi and infection with HIV, EBV and malaria: results from a case-control study.
    Mutalima N; Molyneux E; Jaffe H; Kamiza S; Borgstein E; Mkandawire N; Liomba G; Batumba M; Lagos D; Gratrix F; Boshoff C; Casabonne D; Carpenter LM; Newton R
    PLoS One; 2008 Jun; 3(6):e2505. PubMed ID: 18560562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Revisiting the effect of acute P. falciparum malaria on Epstein-Barr virus: host balance in the setting of reduced malaria endemicity.
    Jayasooriya S; Hislop A; Peng Y; Croom-Carter D; Jankey Y; Bell A; Dong T; Rowland-Jones S; Rickinson A; Walther M; Whittle H
    PLoS One; 2012; 7(2):e31142. PubMed ID: 22347443
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr virus and its role in the pathogenesis of Burkitt's lymphoma: an unresolved issue.
    Bornkamm GW
    Semin Cancer Biol; 2009 Dec; 19(6):351-65. PubMed ID: 19619654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus-malaria interaction models for Burkitt's lymphoma: implications for preventive trials.
    Morrow RH; Gutensohn N; Smith PG
    Cancer Res; 1976 Feb; 36(2 pt 2):667-9. PubMed ID: 175923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBV
    Uccini S; Al-Jadiry MF; Cippitelli C; Talerico C; Scarpino S; Al-Darraji AF; Al-Badri SAF; Alsaadawi AR; Al-Hadad SA; Ruco L
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27399. PubMed ID: 30207048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
    Carpenter LM; Newton R; Casabonne D; Ziegler J; Mbulaiteye S; Mbidde E; Wabinga H; Jaffe H; Beral V
    Int J Cancer; 2008 Mar; 122(6):1319-23. PubMed ID: 18000823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Burkitt lymphoma risk shows geographic and temporal associations with
    Broen K; Dickens J; Trangucci R; Ogwang MD; Tenge CN; Masalu N; Reynolds SJ; Kawira E; Kerchan P; Were PA; Kuremu RT; Wekesa WN; Kinyera T; Otim I; Legason ID; Nabalende H; Buller ID; Ayers LW; Bhatia K; Biggar RJ; Goedert JJ; Wilson ML; Mbulaiteye SM; Zelner J
    Proc Natl Acad Sci U S A; 2023 Jan; 120(2):e2211055120. PubMed ID: 36595676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated anti-Zta IgG levels and EBV viral load are associated with site of tumor presentation in endemic Burkitt's lymphoma patients: a case control study.
    Asito AS; Piriou E; Odada PS; Fiore N; Middeldorp JM; Long C; Dutta S; Lanar DE; Jura WG; Ouma C; Otieno JA; Moormann AM; Rochford R
    Infect Agent Cancer; 2010 Jul; 5():13. PubMed ID: 20667138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sickle cell allele HBB-rs334(T) is associated with decreased risk of childhood Burkitt lymphoma in East Africa.
    Hong HG; Gouveia MH; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Wang X; Zhou J; Leal TP; Otim I; Legason ID; Nabalende H; Dhudha H; Mumia M; Baker FS; Okusolubo T; Ayers LW; Bhatia K; Goedert JJ; Woo J; Manning M; Cole N; Luo W; Hicks B; Chagaluka G; Johnston WT; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Hutchinson A; Yeager M; Adeyemo AA; Thein SL; Rotimi CN; Chanock SJ; Prokunina-Olsson L; Mbulaiteye SM
    Am J Hematol; 2024 Jan; 99(1):113-123. PubMed ID: 38009642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology of Burkitt's lymphoma in Northwest Province, Cameroon, 2003-2010.
    Lewis N; Young J; Hesseling PB; McCormick P; Wright N
    Paediatr Int Child Health; 2012 May; 32(2):82-5. PubMed ID: 22595214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oro-facial manifestations of Burkitt's lymphoma: an analysis of 680 cases from Malawi.
    Mlotha J; Naidoo S
    SADJ; 2011 Mar; 66(2):77-9. PubMed ID: 21608501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Malignant lymphoma in African children: three decades of discovery.
    O'Conor GT
    Princess Takamatsu Symp; 1987; 18():137-47. PubMed ID: 2852187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.
    Okano M; Gross TG
    Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Kelly G; Bell A; Rickinson A
    Nat Med; 2002 Oct; 8(10):1098-104. PubMed ID: 12219084
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between Plasmodium falciparum malaria prevalence, genetic diversity and endemic Burkitt lymphoma in Malawi.
    Johnston WT; Mutalima N; Sun D; Emmanuel B; Bhatia K; Aka P; Wu X; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Batumba M; Carpenter LM; Jaffe H; Molyneux EM; Goedert JJ; Soppet D; Newton R; Mbulaiteye SM
    Sci Rep; 2014 Jan; 4():3741. PubMed ID: 24434689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.